🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Eligible patients will receive subcutaneous vaccinations of the hTERT/survi...
Status
Completed
Location
Abramson Cancer Center, University of Pennsylvania
Start Date
2012-06
Trial ID
NCT01660529
Treatments Being Tested
Open-label, single-arm, multi-center, Phase IIa study to evaluate the effic...
Status
Unknown
Location
Research Site
Start Date
2016-12-22
Trial ID
NCT03190824
Treatments Being Tested
This research trial studies tumor samples from patients with ependymoma tre...
Status
Completed
Location
Children's Oncology Group
Start Date
2012-03
Trial ID
NCT01407744
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of GV100...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-07
Trial ID
NCT05303701
Treatments Being Tested
The primary aim of this innovative immunotherapy using WT1/hTERT/Survivin-l...
Status
Unknown
Location
Department of hematology
Start Date
2021-07-01
Trial ID
NCT05000801
Treatments Being Tested
We try to assess the potential role of telomerase reverse transcriptase and...
Status
Completed
Location
Urology and Nephrology Center
Start Date
2018-08-01
Trial ID
NCT03591367
Treatments Being Tested
INVAC-1 is intended to be used for the treatment of adult patients with adv...
Status
Completed
Location
Hôpital Saint Louis
Start Date
2014-11
Trial ID
NCT02301754
Treatments Being Tested
This is a study on how to activate the immune system with a vaccine. The va...
Status
Completed
Location
University of Pennsylvania Medical Center
Start Date
2007-11
Trial ID
NCT00573495
Treatments Being Tested
GX301 is an experimental therapeutic vaccine directed against human telomer...
Status
Completed
Location
S.C. di Oncologia, A.S.O. "Santi Antonio e Biagio e Cesare Arrigo"
Start Date
2014-11
Trial ID
NCT02293707
Treatments Being Tested
The purpose of this research is to develop a new and powerful type of immun...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT01153113
Treatments Being Tested